FDA Fully Lifts Clinical Hold on Intellia Therapeutics' CRISPR Gene Therapy Trials for ATTR Amyloidosis on March 04, 2026 ATTR-CM ATTRv-PN Clinical Clustered Regularly Interspaced Short Palindromic Repeats Degree or extent gene therapy Intellia nex-z nexiguran United States Food and Drug Administration ziclumeran +